Tag: Pharma
“Popularity of biosimilars will continue to rise, attracting more interest &...
Ravikrishna Chebolu, General Manager, India, West Pharmaceutical Services, Inc. talks about company’s product offerings, latest activities, market trends, unique strategies and future outlook.
Empowering Patient Recruitment in India’s Clinical Trials
We must follow a multi-pronged approach that acknowledges the country's unique cultural tapestry, leverages technology, fosters collaboration, and prioritizes ethical practices, writes Krutikesh Age
Credit profile of Indian pharma companies to remain healthy in FY2025:...
Revenue growth to moderate to 8-10% in FY2025, post a healthy 13-14% YoY expansion in FY2024
India must tap the full potential of phytopharma
The phytopharma industry is not merely about embracing traditional practices but also about subjecting them to rigorous scientific scrutiny
FACE TO FACE: Manoj Kochar, President, Authentication Solution Providers Association (ASPA)
In a freewheeling conversation, Manoj Kochar, President, Authentication Solution Providers Association (ASPA) demystifies the counterfeiting and the challenges it poses to many industries including pharmaceuticals and medical devices
Sanofi India & Emcure Pharma announce exclusive distribution partnership to broaden...
While SIL will continue to own, import, and manufacture these brands across Sanofi’s plants in India and internationally, Emcure will leverage its strengths to engage healthcare professionals
Cohance Lifesciences to merge with Suven Pharmaceuticals
Cohance's ADC Platform addition further strengthens Suven’s position in the high growth CDMO segment; also adds lifecycle management capabilities for Innovators
BioAsia 2024: Mega partnership deals steal the show; Telangana CM announces...
Chief Minister of Telangana, Revanth Reddy, announces INR 1 Lakh crores for pharma villages comprising Vikarabad also announced the next phase of Genome Valley in 300 acres of land
Takeda oncology pipeline remains robust despite shift in focus from CAR-T...
Despite these adjustments, the Japan-based pharma major's oncology pipeline remains robust, says GlobalData
Indian & global big pharma players join forces for NMEs commercialization...
As per the GlobalData, this strategic alliance brings together the strengths and resources of both parties to accelerate commercialization






























































